Internal Medicine Department, College of Medicine, King Faisal University, Alahsa, Saudi Arabia.
Nephrology Unit, Internal Medicine Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt.
Ann Med. 2024 Dec;56(1):2411019. doi: 10.1080/07853890.2024.2411019. Epub 2024 Oct 8.
Peritoneal dialysis (PD) is an alternative modality to hemodialysis (HD) for end-stage Kidney disease (ESKD) treatment. However, PD is underutilized, and patients' knowledge about PD is crucial in making an informed decision about the dialysis modality. This study aims to evaluate the knowledge about PD among HD patients and explore the reasons for its underutilization.
A cross-sectional study of 108 HD patients was conducted from August to November 2023, at Al-Jaber Dialysis Center in Al-Ahsa. They interviewed to assess the knowledge about PD and explore the reasons for its underutilization.
The patients' ages ranged from 20 to 80 years, with a mean age of 44.2 years. Regarding knowledge about PD, 81.5% of the ESKD patients had heard about other renal replacement modalities, with kidney transplant being the most commonly known option. Only 11.1% were aware of both kidney transplants and PD. 60.2% of patients reported that their nephrologists had discussed other treatment options with them. However, overall knowledge about PD among patients was relatively low, with 43.5% having good knowledge and 56.5% having poor knowledge. Lack of information, considering HD as a better method, and fear of complications were the primary reasons for not considering PD as the first treatment option.
This study highlights the inadequate knowledge about PD among HD patients and identifies factors contributing to the underutilization of PD. Lack of information, misconceptions about the effectiveness and safety of PD, and preference for HD were significant barriers. Enhancing patient education and addressing misconceptions are crucial in promoting PD as a viable treatment option for ESKD, thereby improving patients' quality of life.
腹膜透析(PD)是终末期肾病(ESKD)治疗的血液透析(HD)替代方式。然而,PD 的使用率较低,患者对 PD 的了解对于就透析方式做出明智决策至关重要。本研究旨在评估 HD 患者对 PD 的了解,并探讨 PD 使用率低的原因。
2023 年 8 月至 11 月,在阿赫萨的 Al-Jaber 透析中心进行了一项横断面研究,对 108 名 HD 患者进行了访谈,以评估他们对 PD 的了解,并探讨 PD 使用率低的原因。
患者年龄在 20 至 80 岁之间,平均年龄为 44.2 岁。关于 PD 的知识,81.5%的 ESKD 患者听说过其他肾脏替代方式,其中肾移植是最常见的选择。只有 11.1%的患者同时了解肾移植和 PD。60.2%的患者报告说,他们的肾病医生曾与他们讨论过其他治疗方案。然而,患者对 PD 的总体了解相对较低,43.5%的患者具有良好的知识,56.5%的患者知识较差。缺乏信息、认为 HD 是更好的方法以及担心并发症是不考虑 PD 作为首选治疗方案的主要原因。
本研究强调了 HD 患者对 PD 的了解不足,并确定了导致 PD 使用率低的因素。缺乏信息、对 PD 的有效性和安全性的误解以及对 HD 的偏好是主要障碍。加强患者教育和纠正误解对于推广 PD 作为 ESKD 的可行治疗选择至关重要,从而提高患者的生活质量。